Answers are grounded in this paper and cite their sources.
The ongoing COVID-19 pandemic is as an outbreak of pneumonia caused by a novel coronavirus (nCoV).The information, knowledge and treatment about COVID-19 is in a fast gear as it is changing everyday since clinicians and researchers all over the world are trying currently available drugs like chloroquine, hydroxychloroquine, azithromycin, convalescent plasma, lopinavir-ritonavir, remdesivir etc., to eradicate this menace.Till date, the best and quick results have been shown by the use of hydroxychloroquine and azithromycin.The combination has shown almost 100% recovery of COVID-19 patients with cautioned administration considering patient's cardiac history, if the benefits outweighs the associated risks.The convalescent plasma therapy too has shown good results for COVID-19 patients.The patients having severe respiratory problems like Acute Respiratory Distress Syndrome get resolved in 4 patients after 12 days of transfusion and 3 patients were removed from mechanical ventilation within 2 weeks of treatment.This therapy has not yet reported any adverse events though ABO blood type matching should be done before convalescent plasma transfusion from donor to receiver.Though, the number of patients used for clinical trials of hydroxychloroquine-azithromycin combination and convalescent plasma therapy were very less to prove the efficacy of these drugs for COVID-19 treatment.But the use of these drugs should be warranted when human race is facing the devastation caused by SARS-CoV-2 infection.The drug named remdesivir very recently has shown positive results as it is reducing clinical recovery time by almost 4 days or 31% when compared with placebo.The combination of other anti-viral drug lopinavir and ritonavir have not shown any positive results yet.
No takes yet. Share an insight, caveat, or question.
Jawed et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: